News
News
press The 5th Tokyo Metropolitan Public Lecture of FY2026 will be held on Monday, October 26, 2026.
Full article：https://mainichi.jp/articles/20260907/pls/00m/020/555000c
info Presentation at an AMED Public Symposium
Kazusaku Kamiya, Representative Director of Gap Junction Therapeutics, Inc., spoke at the FY2025 Public Symposium on Regenerative Medicine, Cell Therapy, and Gene Therapy organized …
Full article：https://www.amed.go.jp/news/event/saisei_sympo2025.html?utm_source=cha…
media Hokkaido University Launches Joint Research on Gap Junction–Based Drug Discovery for Age-Related and Genetic Hearing Loss — Nikkei Biotech
Full article：https://bio.nikkeibp.co.jp/atcl/release/26/03/13/27506/
info A Review Article by Kazusaku Kamiya Was Published in “Igaku no Ayumi”
Full article：https://webview.isho.jp/journal/detail/abs/10.32118/ayu296100931
info Hearing Loss Gene Repaired with Therapeutic Drug in Mice, New Method Succeeds — Asahi Shimbun
Full article：https://www.asahi.com/articles/AST3G21V7T3GUTFL00WM.html
media Juntendo University Develops Genome Editing Therapy for Hereditary Hearing Loss — Nikkei
Full article：https://www.nikkei.com/article/DGXZQOSG103OQ0Q5A310C2000000/
press Researchers Develop Genome Editing Technology for Hereditary Hearing Loss — Press Release
Full article：https://prtimes.jp/main/html/rd/p/000000741.000021495.html
media Takara Bio Partners with Startup to Develop In Vivo Gene Therapy for Genetic Hearing Loss — Nikkei Biotech
Full article：https://bio.nikkeibp.co.jp/atcl/news/p1/24/06/18/12056/
info Gap Junction Wins Top Prize in Boehringer Ingelheim Pitch for Hearing Loss Treatment
Full article：https://bio.nikkeibp.co.jp/atcl/news/p1/22/09/28/09979/
info Our Website is Now Live
We are pleased to announce that our website is now live.